Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Conduct Disorder

• Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder
• Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
• Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder
• Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders
• Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders
• Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
• Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
• A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation
• Trial of Aripiprazole in the Treatment of CD in Adolescents
• A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation
• Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder
• The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Adolescents With Impulsivity and Aggressive Behavior in Conduct Disorder This Study is Not Being Conducted in the United States.
• Long-Term Lithium Treatment for Aggressive Conduct Disorder